Callio Therapeutics is developing novel dual-payload antibody-drug conjugates (ADCs) designed to address resistance to existing cancer therapies, using proprietary linker and ADC platform technologies ...

SEATTLE and SINGAPORE, March 24, 2026 (GLOBE NEWSWIRE)-- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach ...

Nobel Prize winners, from left: Mary Brunkow, senior program manager at the Institute for Systems Biology, Fred Ramsdell, co-founder and chair of Sonoma Biotherapeutic’s scientific advisory board; and ...

Looking to redefine what’s possible in the mining industry, which poses some of the most extreme challenges in industrial applications and connectivity, Nokia and Boldyn Networks have deployed a ...

Nokia and Boldyn Networks power the future of mining at Callio Pyhäjärvi with private 5G network Deployment enables safer, smarter, and more sustainable operations, where most workforces can operate ...

Press Release Nokia and Boldyn Networks power the future of mining at Callio Pyhäjärvi with private 5G network Deployment enables safer, smarter, and more ...

Nokia and Boldyn Networks power the future of mining at Callio Pyhäjärvi with private 5G network 24 September 2025 Espoo, Finland – Nokia and Boldyn Networks have deployed a private 5G network at the ...

The site was formerly a fully operational copper mine for over 60 years and one of Europe’s deepest, and now functions as a real-world mining environment where technology companies can test and ...

Nokia and Boldyn Networks have deployed a private 5G network at the Callio FutureMINE site in Pyhäjärvi, Finland, transforming one of Europe’s deepest mines into a next-generation testbed for mining ...

Deployment enables safer, smarter, and more sustainable operations, where most workforces can operate from above ground. 24 September 2025 Espoo, Finland – Nokia and Boldyn Networks have deployed a ...